Latest Therapeutic Solutions International Inc (TS

Latest Therapeutic Solutions International Inc (TSOI) Headlines

Therapeutic Solutions International, Inc. Announces Memorandum of Understanding With ZYPPAH, Inc.
Marketwire - Tue Aug 06, 8:00AM CDT
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today a collaboration with ZYPPAH, Inc., in efforts to promote ZYPPAH's professional education classes wherein TSI's Sleepwell(R) product will be included as a therapeutic option and recommendation for dentists attending ZYPPAH's professional education classes.

Therapeutic Solutions International, Inc. Announces Definitive Agreement With S4S (UK) Limited
Marketwire - Tue Jun 18, 8:01AM CDT
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the signing of a Distribution Agreement with S4S (UK) Limited for exclusive distribution rights in the United States to market the U.S. patented and FDA cleared titratable sleep appliance hardware sold under the trademark "Sleepwell(TM)".

Therapeutic Solutions International, Inc. Announces Formation of Scientific Advisory Board
Marketwire - Tue Jun 11, 8:01AM CDT
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the creation of a Scientific Advisory Board with Dr. Barry Glassman appointed as Chairman.

Therapeutic Solutions International, Inc. Announces the Appointment of Dr. Barry Glassman as Vice President of Training and Education
Marketwire - Mon Feb 11, 8:01AM CST
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the appointment of Barry Glassman, D.M.D., as Vice President of Training and Education.

Therapeutic Solutions International, Inc. Announces Investor Conference Call Hosted by Company CEO Tim Dixon
Marketwire - Tue Feb 05, 8:15AM CST
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today it will host an investor conference call at 4:15 p.m. Eastern Standard Time on Tuesday, February 12.

Therapeutic Solutions International, Inc. Announces New Distribution Agreement With Dentorient Fuss Ltd., of Tel Aviv, Israel
Marketwire - Tue Jan 29, 8:15AM CST
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the signing of a distribution agreement with Dentorient Fuss Ltd., a dental supply company headquartered in Tel Aviv, Israel.

Therapeutic Solutions International, Inc. Announces New Distribution Agreement With Smile Cosmetic SARL, of Casablanca, Morocco
Marketwire - Thu Jan 24, 8:00AM CST
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the signing of an agreement with Smile Cosmetic SARL for the distribution of Therapeutic Solutions International's AMPSA products in Morocco.

Therapeutic Solutions International, Inc. Reacquires and Retires 223,991,933 Shares of Its Common Stock, Successfully Makes Final Payment of Royalties
Marketwire - Tue Jan 22, 8:15AM CST
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today that pursuant to the previously announced terms of an August 2012 agreement with James P. Boyd, the Company has reacquired 223,991,933 shares of Company common stock from Mr. Boyd and retired the shares, reducing its total number of outstanding shares from approximately 305.5 million to approximately 81.5 million.

Therapeutic Solutions International, Inc. Announces Regulatory Approval to Market the Migran-X(R) Device for Migraine Prevention Into the Brazilian Market
Marketwire - Mon Jan 07, 8:01AM CST
Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the completion of approval of its AMPSA products with Brazil's National Health Surveillance Agency ("ANVISA") for immediate sale into the Brazilian market.